Controversies in Glaucoma 2025 PDF

Controversies in Glaucoma 2025 Disclosures...

Controversies in Glaucoma 2025 Disclosures Controversies Michael Chaglasian, O.D. Alcon- Advisory Board, Speaker Bureau in Glaucoma B+L- Advisory Board, Speaker Bureau Carl Zeiss - Consultant, Advisory Board iCare – Consultant Optos - Research Thea – Consultant Topcon- Consultant Michael Chaglasian, OD, FAAO Illinois College of Optometry Chicago, IL [email protected] 1 2 Controversies in Glaucoma - Topics Is there a role for nutraceuticals/supplements in the therapy of glaucoma? Is there a role for Should Genetic Testing be Part of the Glaucoma Workup? Should SLT Be The First Therapy Utilized for OHTN/Open nutraceuticals/supplements or Angle Glaucoma? vitamins in the therapy of Is It Time That We Move on from Goldmann tonometry? glaucoma? Can AI diagnose glaucoma? Do We Still Need Visual Fields if We are Using an OCT? 3 4 Some promising supplements include: There is growing interest in the role of nutraceuticals and  Ginkgo biloba: supplements as adjunctive therapy for glaucoma.  Known for its antioxidant properties, it may help improve blood flow to the optic nerve3. While traditional treatments focus on lowering intraocular  Nicotinamide (Vitamin B3): pressure (IOP), nutraceuticals may offer additional benefits  Studies suggest it may support retinal ganglion cell survival and improve visual function2. through their neuroprotective, antioxidant, and anti- inflammatory properties12.  Citicoline:  This supplement has shown potential in enhancing visual pathway function and protecting retinal cells2. 5 6 M. Chaglasian, OD 1 Controversies in Glaucoma 2025 Nutraceuticals/supplements and glaucoma Neuroprotection What does the clinician do when their glaucoma patient is getting worse with the IOP appearing to be controlled? Glaucoma in most individuals is a slowly progressive disease Small number (